Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023
Objectives: We evaluated the vaccine effectiveness of monovalent XBB.1.5 vaccine against symptomatic COVID-19 infection, hospitalization, and the need for oxygen therapy in South Korea. Design: This study employed a test-negative case-control design. COVID-19 test results in symptomatic subjects fro...
Saved in:
| Main Authors: | Jung Ah Lee, Heeseon Jang, Sang Min Ahn, Jae Eun Seong, Young Keun Kim, Yujin Sohn, Sook In Jung, Hye Won Jeong, Shin-Woo Kim, Jin-Soo Lee, Ji-Hyeon Baek, Se Ju Lee, Geun-Yong Kwon, Jeeyeon Shin, Hangjin Jeong, Changsoo Kim, Jun Yong Choi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | International Journal of Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971224003205 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster
by: Yun Sang Tang, et al.
Published: (2024-12-01) -
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
by: Juan Manuel Carreño, et al.
Published: (2025-04-01) -
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells
by: Joel Sop, et al.
Published: (2025-03-01) -
Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea
by: Jin Sun No, et al.
Published: (2024-12-01) -
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
by: Julia N. Faraone, et al.
Published: (2023-12-01)